To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05682170
Contacts
| Contact: K-Group Alpha, Inc. a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | (212) 433-3791 | info@zenopharma.com |
Locations
| United States, Alabama | |
| Investigative Site 0108 | Not yet **RECRUITING NOW** |
| Birmingham, Alabama, United States, 35233 | |
| United States, California | |
| Site 0266 | Not yet **RECRUITING NOW** |
| San Francisco, California, United States, 94110 | |
| United States, New York | |
| Site 0105 | **RECRUITING NOW** |
| New York, New York, United States, 10065 | |
Sponsors and Collaborators
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Investigators
| Study Director: | K-Group Alpha, Inc. a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | K-Group Alpha |
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
